{"name":"Atlas Molecular Pharma","slug":"atlas-molecular-pharma","ticker":"","exchange":"","domain":"atlasmolecularpharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ciclopirox Olamine Oral","genericName":"Ciclopirox Olamine Oral","slug":"ciclopirox-olamine-oral","indication":"Onychomycosis (fungal nail infection)","status":"phase_3"}]}],"pipeline":[{"name":"Ciclopirox Olamine Oral","genericName":"Ciclopirox Olamine Oral","slug":"ciclopirox-olamine-oral","phase":"phase_3","mechanism":"Ciclopirox olamine is a broad-spectrum antifungal agent that inhibits fungal cytochrome P450 enzymes and disrupts fungal cell membrane integrity.","indications":["Onychomycosis (fungal nail infection)","Systemic fungal infections"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBzSUZ2VE83YU45cFRGMEtVeHRxZG5JZFgyVUtMNC1WVWN5WE5GX2xWM1NJdnV6SmJvYWZKRGJ5eVppd2tia2VBaEhmUEwtWVdRbEdaSHBuUGMzSTlIeEpSdU4xeWhMQm9oeTFJVHpNY2xpZw?oc=5","date":"2026-04-06","type":"pipeline","source":"慶應義塾","summary":"Launch of the Lipidome Atlas Project to Explore the Essence of Life - 慶應義塾","headline":"Launch of the Lipidome Atlas Project to Explore the Essence of Life - 慶應義塾","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQSG1TUkVMbmphSFV1QnZtZ0VXM1VkZm1TVEt5dXp3MnZoVS1EZ1ZKbDV6RXg4dTFqR2hkelhfM3NSeElOOGtnMWlQM3k5aE40cmVsWWFoOGhhVXBfNWw1ck9FZlp3c2l6Q3JheHFPVEFja0xJRUlIMTMtdmZDZzF3NHV2MUZJanZNUVpIQm1VSkVwcnJhQXd5Rk9oWnlfRS0wSXBQeDZSVQ?oc=5","date":"2026-01-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery - Pharmaceutical Technology","headline":"JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNaS1kcVFDNmhTanFrZXdvdTdmUDFSU2FYTHAyQnpNX1lTaUtTQ3ZWeHlPeVoySXhsNkplbUpKdzdzc0ZkMEdmeklYRTRYeFlEREpNMm0wTEhBUVI5OEdZRkRkZ1hiRnJqQ2JYWlNPTnlESWRuUDQwNjRES0F2WHlVQldidlF6endkZU4zcUNrRGF1MWpsc2h3NUZDRFBRcDMzaTFB?oc=5","date":"2025-12-03","type":"trial","source":"GenomeWeb","summary":"Illumina, Other Genomics Firms Ramp Up Data Offerings for Pharma, With Eyes on AI - GenomeWeb","headline":"Illumina, Other Genomics Firms Ramp Up Data Offerings for Pharma, With Eyes on AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE0tOXVhNVdOYTlfeXRsdlNiRlBWYkdQY0lJb0oxb1dSX0JmM0R2RkVaX1J1QkFiYlU0WmhSMTdEU01XYUpzRFhNXzVnWEFEQ0JuRXVj?oc=5","date":"2025-12-03","type":"pipeline","source":"FirstWord Pharma","summary":"Pfizer, Regeneron back TRIANA's $120M raise to advance lead molecular glue - FirstWord Pharma","headline":"Pfizer, Regeneron back TRIANA's $120M raise to advance lead molecular glue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQUDE1M2NxRWt5REc5dVBtU25CbXlRbTJDMzhrZHJxS2ZhcExzdUszTEh5QXlxTGh2UEU2YWoyRVVoWDdUdUdVMWFUem52MTc0bkJueEthZ1VWMXRZWHFRb0dYNTBDS1NBaVRNOU1uTW1XXzI2cldNRkw4WWVENHV0X0dRcmdEb0NBbEhoSkZrUDRzZ1FTY3U5NHB4aWlVc0xSQUFCVVVyNU1aMThTSFE5dkpCak1ZOWRKQzFVUHZ6dVlST2FxVjJTSTlwZl9URGNRRmowOXFsM3RuXzRSVXQ0UWh1Wmg4aFk?oc=5","date":"2025-11-19","type":"pipeline","source":"BioPharma APAC","summary":"10x Genomics And ASTRA Consortium Launch Asia Pacific Pan Cancer Spatial Atlas To Advance Precision Oncology - BioPharma APAC","headline":"10x Genomics And ASTRA Consortium Launch Asia Pacific Pan Cancer Spatial Atlas To Advance Precision Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZGJJVFVwaHBHRG82bThjbEZnbTUwbDJXWXZtbW9QdHR1YXkzWUJIanlxcXNxcS1JeUxYVFFDdV95Z1AyQjAzdnVCNWtTbnhfS05SVlZVWW1MTXR0eU9Pc0JIa3lIeVBId2xIc08wUFJuRWFFcGF2U3BXNlI1aktYdU1VdGRURnk1ZXVkOUxrSXVDcDItQlB3eDlnN1NfclFTSFM3MkZWd3Q?oc=5","date":"2025-09-05","type":"pipeline","source":"C&EN","summary":"In the rise of Chinese biotech, some see opportunity. Others see a threat - C&EN","headline":"In the rise of Chinese biotech, some see opportunity. Others see a threat - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOWWRPYl9YcFUwRzBtVUZvTnlMd3h0bWRVTGJFc2htOFM0akh1aHdjRmJZTzJKRDk2LVI1LXlfUm12QWluV1RwUUR6bVJ1cXZwbURSYXBFVWlOVEtmQ0R1aS12VVZoLW9HdWtlc05mSmhzNXVjUUdrV3ZoLVdQTFZHSG90V3NQZEZPZ2E1U095YnFOUzl5eWdFYU1R?oc=5","date":"2025-08-18","type":"pipeline","source":"the-scientist.com","summary":"How a Small Lab Took on One of the World’s Rarest Diseases - the-scientist.com","headline":"How a Small Lab Took on One of the World’s Rarest Diseases - the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFB3cW83ZnJtd3Y3bEM4dmc4VGlKa2dIaFBuTEdyakNxVFhXNFE0SjQwMXNhbjRPd1A4N3JaNGhpdUxwTktoUlplRkZMNTA5SDRoZDVpakp3eml5R19pNjBhUWk5d0syQQ?oc=5","date":"2025-07-23","type":"pipeline","source":"New Atlas","summary":"World-first obesity pill reprograms fat cells to burn calories with zero effort - New Atlas","headline":"World-first obesity pill reprograms fat cells to burn calories with zero effort","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQaGZPUWRfbC00cEU5Sk53T3YxaVhwanhSMkVlcHZoQ21WR2dIY3BwWS1uMXV2eHh6WDBRM19LQmh1X19XQ2tTS3FITC10c1NBUWM5Z2ZNYzdmaE1XU1hkRUFYSTdEQUFTcXBaY0NiY253Vk0xOUgwVlVudXZFNmtpTGI0QlUweTdIbnZlSm1ubFNoYWc2RjdIYnFQVWxyYjVsQmwyQ1VfQXdJWFNGcFQ3VVpTeU5pbUtPOWFvNTI2eUJ2VkN2SUZTRW1lcEZiTjZMQ0NSeTRGbE5od3Z4RXR5bEZvODQyaDdtYmpvY3BJQ1lsY2M0ZVJ1T0E5VW9KMTQ?oc=5","date":"2025-06-27","type":"trial","source":"BioSpace","summary":"Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation - BioSpace","headline":"Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Da","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPTTN1cEFYQlI5N1RuYzkxQlVVYmYxTGJ6cXMxRDZxc2wtaUNPb2xEOEMxWjFCbUd5QVhrZU9BR0lVNWsyX01pcV9IbzJkdGdMczNjcmluSTZ4d0tzeFYyTTNuaTMzREFCdEpiSTdYd0pzc3NVMzR0b0pXeTJkWUpRMTZUYU5BMTFVNkE3b1h2bzlWLXFUTWxJN042X2VDWVFiT2hGb2lKa3lMNlRnbmZ1bUk0Wmp1ZlRXQk4xSzJkbjdYbVNmR2tIcDlTZVBOZnZ5QkxfS1g2dw?oc=5","date":"2025-06-17","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell - Genetic Engineering and Biotechnology News","headline":"Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNU2xWWDlia1ptemxwNXo4ZDJrTW50NkpMUjZ5RXlWOUhKVUI4U3N4MjFRVHdSWVFqcWZvZkV2cTRBdFBBOHVGSnI0cHVLZVpqcmhGVlRJeF9mS1VHcGltOGk0SEM2M2NXQWtQX0dTeXFPbF95VEQ2aU5HZ0t4WllyUjlVQzBYUTR2?oc=5","date":"2025-05-30","type":"pipeline","source":"pharmaphorum","summary":"GRIN raises $140m for epilepsy drug, and other financings - pharmaphorum","headline":"GRIN raises $140m for epilepsy drug, and other financings","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}